Search results
Found 20343 matches for
The results of a placebo-controlled randomised trial of remdesivir in COVID-19 patients have been published in the Lancet. Supported by the ISARIC Support Centre, scientists in China launched a trial of remdesivir in patients hospitalised with COVID-19. The results found no clinical benefit from use of the drug; however, while not statistically significant, the time to clinical improvement and duration of invasive mechanical ventilation were shorter in people treated with remdesivir.
Susanna Dunachie
Principal Investigators Research Scientists
Susanna Dunachie - Professor of Infectious Diseases
Paul Turner
Principal Investigators Research Scientists
MB BS, PhD, FRCPCH, FRCPath Paul Turner - Professor of Paediatric Microbiology
Stuart Blacksell
Principal Investigators Research Scientists
Stuart Blacksell - Professor of Tropical Microbiology
Mehul Dhorda
Research Scientists
Mehul Dhorda - DeTACT-Africa Coordinator / Head of Specimen Management Laboratory
Eduard Sanders
Principal Investigators Research Scientists
Eduard Sanders - Professor of global health practice
Hoa Thi Ngo
MSc IHTM Lecturers Principal Investigators Research Scientists
Hoa Thi Ngo - Associate Professor
Raph Hamers
Principal Investigators Research Scientists
MD PhD Raph Hamers - Associate Professor in Infectious Diseases
David Warrell
Principal Investigators Research Scientists
DM, DSc, FRCP, FRCPE, FMedSci; HonF CeylonCP, RThaiCP, WestAfrCP, CPSMumbai David Warrell - Emeritus Professor of Tropical Medicine
Frank Smithuis
Principal Investigators Research Scientists
Frank Smithuis - Professor of Tropical Medicine
Lorenz Von Seidlein
Principal Investigators Research Scientists
Lorenz Von Seidlein - Professor of Global Health